375 Participants Needed

Mobile Health Exercise Regimen for Heart Valve Disease

(HOMERUNHITTER Trial)

AV
CH
Overseen ByCaleb Hayes, MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Vanderbilt University Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.

What data supports the effectiveness of the treatment Home-Based Cardiac Rehabilitation for heart valve disease?

Research shows that home-based cardiac rehabilitation (HBCR) using smartphone interaction is effective in reducing major adverse cardiac events and improving exercise capacity in patients with coronary heart disease, suggesting potential benefits for heart valve disease patients as well.12345

Is home-based cardiac rehabilitation safe for humans?

Research indicates that home-based cardiac rehabilitation (HBCR) is generally safe for patients with coronary heart disease, showing lower rates of major adverse cardiac events and unscheduled readmissions compared to usual care.12346

How is the Home-Based Cardiac Rehabilitation treatment different from other treatments for heart valve disease?

Home-Based Cardiac Rehabilitation (HBCR) is unique because it allows patients to perform their cardiac rehabilitation exercises at home, often using smartphone apps for guidance and monitoring, which can improve exercise capacity and reduce cardiac risks without needing frequent hospital visits.13789

What is the purpose of this trial?

The vast majority of cardiac rehabilitation eligible individuals do not participate in center based cardiac rehabilitation (CBCR). While steps to encourage participation in CBCR are important, many individuals will still not participate for a variety of reasons. This randomized controlled trial is evaluating a home-based cardiac rehabilitation (HBCR) intervention delivered using a custom app and digital tools in patients undergoing transcatheter heart valve interventions (THVIs). After a brief roll-in period, participants not intending to participate in CBCR are randomized to one of three groups: (1) control, (2) HBCR mobile health intervention with hands-off delivery, and (3) HBCR mobile health intervention with interactive delivery. Participants in the intervention groups (hands-off/interactive delivery) will also be randomized to continue the intervention for 12 weeks or 24 weeks. The intervention targets key health behaviors and includes traditional cardiac rehabilitation components. The study will assess the effect of the intervention on clinical events, physical activity, quality of life, and other outcomes. Those who intend to participate in CBCR will be followed in a registry.

Research Team

Brian R Lindman

Brian R. Lindman, MD

Principal Investigator

Vanderbilt University Medical Center

Eligibility Criteria

This trial is for heart valve disease patients who've had a transcatheter heart valve intervention via the leg. They must be able to use an activity tracker, not planning on joining center-based rehab, and capable of using digital tools without physical or mental limitations that would interfere.

Inclusion Criteria

I have had a heart valve procedure without open surgery.

Exclusion Criteria

Treating provider or site PI indicates that participation in the study would be unsafe
I had a stroke during or right after my heart valve procedure.
I can walk on my own but may use a cane.
See 10 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Roll-in

Brief roll-in period before randomization

1-2 weeks

Treatment

Participants receive home-based cardiac rehabilitation using a mobile app, randomized to either hands-off or interactive delivery for 12 or 24 weeks

12-24 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

24-30 months

Treatment Details

Interventions

  • Home-Based Cardiac Rehabilitation
Trial Overview The study tests a home-based cardiac rehab program delivered through an app and digital tools after heart valve surgery. Participants are randomly assigned to control, hands-off mobile health intervention, or interactive mobile health intervention for either 12 or 24 weeks.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: HBCR interactiveExperimental Treatment1 Intervention
Home-based cardiac rehabilitation with mobile application and periodic video calls with exercise physiologist + AHA Life's Essential 8 sheets.
Group II: HBCR hands-offExperimental Treatment1 Intervention
Home-based cardiac rehabilitation with mobile application + AHA Life's Essential 8 sheets.
Group III: ControlActive Control1 Intervention
Standard of care course for an individual not participating in center based cardiac rehabilitation. AHA Life's Essential 8 Fact Sheets are provided to promote healthy living.

Home-Based Cardiac Rehabilitation is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Cardiac Rehabilitation for:
  • Coronary artery disease
  • Heart failure
  • Post-myocardial infarction rehabilitation
  • Post-percutaneous coronary intervention rehabilitation
  • Post-coronary artery bypass grafting rehabilitation
🇺🇸
Approved in United States as Cardiac Rehabilitation for:
  • Coronary artery disease
  • Heart failure
  • Post-myocardial infarction rehabilitation
  • Post-percutaneous coronary intervention rehabilitation
  • Post-coronary artery bypass grafting rehabilitation
🇨🇦
Approved in Canada as Cardiac Rehabilitation for:
  • Coronary artery disease
  • Heart failure
  • Post-myocardial infarction rehabilitation
  • Post-percutaneous coronary intervention rehabilitation
  • Post-coronary artery bypass grafting rehabilitation

Find a Clinic Near You

Who Is Running the Clinical Trial?

Vanderbilt University Medical Center

Lead Sponsor

Trials
922
Recruited
939,000+

Wake Forest University Health Sciences

Collaborator

Trials
1,432
Recruited
2,506,000+

Morristown Medical Center

Collaborator

Trials
3
Recruited
820+

Piedmont Healthcare

Collaborator

Trials
23
Recruited
5,700+

Inova Fairfax Hospital

Collaborator

Trials
12
Recruited
7,700+

Chattanooga-Hamilton County Hospital Authority

Collaborator

Trials
4
Recruited
640+

Medical University of South Carolina

Collaborator

Trials
994
Recruited
7,408,000+

Duke Clinical Research Institute

Collaborator

Trials
69
Recruited
242,000+

University of Michigan

Collaborator

Trials
1,891
Recruited
6,458,000+

Pinnacle Health Cardiovascular Institute

Collaborator

Trials
3
Recruited
1,500+

Findings from Research

The Veterans Affairs home-based cardiac rehabilitation (HBCR) program showed significant improvements in various health metrics among 923 veterans, including increased exercise capacity, reduced depression, and better eating habits, with no reported safety issues.
With a completion rate of 62%, the HBCR program was well-received by participants, indicating it is an effective and safe alternative to traditional site-based cardiac rehabilitation, especially for patients with complex health needs.
Home-Based Cardiac Rehabilitation: EXPERIENCE FROM THE VETERANS AFFAIRS.Drwal, KR., Wakefield, BJ., Forman, DE., et al.[2023]
Both home-based cardiac rehabilitation (HBCR) and center-based cardiac rehabilitation (CBCR) significantly improved cardiovascular risk factors such as low-density lipoprotein levels, eating habits, and psychological status in a study of 72 patients over 6 months.
While both programs enhanced exercise duration and metabolic equivalents, CBCR showed slightly better improvements, suggesting that both types of rehabilitation can effectively modify patient lifestyles, even though smoking rates increased in both groups.
The Effect of Home-Based Cardiac Rehabilitation on Cardiovascular Risk Factors Management.Kim, C., Lee, SH.[2023]
The smartphone-facilitated home-based cardiac rehabilitation (HBCR) model significantly reduced major adverse cardiac events (MACE) in patients with coronary heart disease, with an incidence of 1.5% in the HBCR group compared to 8.9% in the control group over a follow-up of up to 42 months.
Patients in the HBCR group also experienced improved exercise capacity and quality of life, evidenced by higher maximal METs and better scores on the Seattle Angina Questionnaire, indicating that this model is both safe and effective for enhancing patient wellness.
Chinese Home-Based Cardiac Rehabilitation Model Delivered by Smartphone Interaction Improves Clinical Outcomes in Patients With Coronary Heart Disease.Ma, J., Ge, C., Shi, Y., et al.[2021]

References

Home-Based Cardiac Rehabilitation: EXPERIENCE FROM THE VETERANS AFFAIRS. [2023]
The Effect of Home-Based Cardiac Rehabilitation on Cardiovascular Risk Factors Management. [2023]
Chinese Home-Based Cardiac Rehabilitation Model Delivered by Smartphone Interaction Improves Clinical Outcomes in Patients With Coronary Heart Disease. [2021]
Safety of home-based cardiac rehabilitation: A systematic review. [2022]
Home-Based Cardiac Rehabilitation Among Patients Unwilling to Participate in Hospital-Based Programs. [2023]
Comparison of Home-Based vs Center-Based Cardiac Rehabilitation in Hospitalization, Medication Adherence, and Risk Factor Control Among Patients With Cardiovascular Disease. [2022]
Effects of home-based cardiac exercise program on the exercise tolerance, serum lipid values and self-efficacy of coronary patients. [2019]
Home-based cardiac rehabilitation using information and communication technology for heart failure patients with frailty. [2022]
Effects of exercise-based cardiac rehabilitation delivery modes on exercise capacity and health-related quality of life in heart failure: a systematic review and network meta-analysis. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security